fluphenazine depot has been researched along with cocaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamble, G; Greenstein, RA; McLellan, AT; Stone, AM | 1 |
| Dhopesh, V; Gamble, G; Maany, I; Macfadden, A | 1 |
2 other study(ies) available for fluphenazine depot and cocaine
| Article | Year |
|---|---|
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Veterans | 1993 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia | 1997 |